236 related articles for article (PubMed ID: 31764674)
1. Fat Grafting for the Treatment of Scleroderma.
Strong AL; Rubin JP; Kozlow JH; Cederna PS
Plast Reconstr Surg; 2019 Dec; 144(6):1498-1507. PubMed ID: 31764674
[TBL] [Abstract][Full Text] [Related]
2. Adipose-Derived Stem Cells Attenuate Skin Fibrosis and Improve Fat Retention of a Localized Scleroderma Mouse Model.
Wang HC; Sun ET; Zhao RC; Chen B; Han Q; Li N; Long X; Wang X
Plast Reconstr Surg; 2023 Jan; 151(1):97-107. PubMed ID: 36206077
[TBL] [Abstract][Full Text] [Related]
3. Aesthetic and therapeutic outcome of fat grafting for localized Scleroderma treatment: From basic study to clinical application.
Wang HC; Dong R; Long X; Wang X
J Cosmet Dermatol; 2021 Sep; 20(9):2723-2728. PubMed ID: 33486881
[TBL] [Abstract][Full Text] [Related]
4. Supportive Use of Adipose-Derived Stem Cells in Cell-Assisted Lipotransfer for Localized Scleroderma.
Chen B; Wang X; Long X; Zhang M; Huang J; Yu N; Xu J
Plast Reconstr Surg; 2018 Jun; 141(6):1395-1407. PubMed ID: 29794702
[TBL] [Abstract][Full Text] [Related]
5. Fat Grafting Subjectively Improves Facial Skin Elasticity and Hand Function of Scleroderma Patients.
Strong AL; Adidharma W; Brown OH; Cederna PS
Plast Reconstr Surg Glob Open; 2021 Jan; 9(1):e3373. PubMed ID: 33552819
[TBL] [Abstract][Full Text] [Related]
6. Regenerative Approach to Scleroderma with Fat Grafting.
Magalon G; Daumas A; Sautereau N; Magalon J; Sabatier F; Granel B
Clin Plast Surg; 2015 Jul; 42(3):353-64, viii-ix. PubMed ID: 26116941
[TBL] [Abstract][Full Text] [Related]
7. Adipose-Derived Stem Cell-Enriched Lipotransfer Reverses Skin Sclerosis by Suppressing Dermal Inflammation.
Jiang W; Wang J; Lin J; Jiang S; Quan Y; Liao Y; Gao J; Cai J
Plast Reconstr Surg; 2022 Sep; 150(3):578-587. PubMed ID: 35759642
[TBL] [Abstract][Full Text] [Related]
8. Localized and systemic scleroderma.
Hawk A; English JC
Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
[TBL] [Abstract][Full Text] [Related]
9. Incisional Release and Fat Grafting for the Surgical Management of Perioral Fibrosis in Scleroderma: A Technical Report and Institutional Review.
Lagziel T; Kawaji Q; Hultman CS
Ann Plast Surg; 2023 Jun; 90(6S Suppl 5):S495-S498. PubMed ID: 36943019
[TBL] [Abstract][Full Text] [Related]
10. Autologous fat transplantation for the treatment of linear scleroderma en coup de sabre.
Ibler KS; Gramkow C; Siemssen PA
Skinmed; 2015; 13(1):74-6. PubMed ID: 25842477
[TBL] [Abstract][Full Text] [Related]
11. Combined platelet-rich plasma and lipofilling treatment provides great improvement in facial skin-induced lesion regeneration for scleroderma patients.
Virzì F; Bianca P; Giammona A; Apuzzo T; Di Franco S; Mangiapane LR; Colorito ML; Catalano D; Scavo E; Nicotra A; Benfante A; Pistone G; Caputo V; Dieli F; Pirrello R; Stassi G
Stem Cell Res Ther; 2017 Oct; 8(1):236. PubMed ID: 29058626
[TBL] [Abstract][Full Text] [Related]
12. Fat Grafting Reduces Skin Hyperpigmentation of Localized Scleroderma Patients: A Prospective Self-controlled Study.
Li Z; Wang HC; Chen J; Li Y; Yu N; Xiao Y; Du F; Wang X; Huang J; Long X
Aesthetic Plast Surg; 2023 Oct; 47(5):2084-2092. PubMed ID: 37592146
[TBL] [Abstract][Full Text] [Related]
13. Clinical Treatment Options in Scleroderma: Recommendations and Comprehensive Review.
Zhao M; Wu J; Wu H; Sawalha AH; Lu Q
Clin Rev Allergy Immunol; 2022 Apr; 62(2):273-291. PubMed ID: 33449302
[TBL] [Abstract][Full Text] [Related]
14. State of the art. Autologous fat graft and adipose tissue-derived stromal vascular fraction injection for hand therapy in systemic sclerosis patients.
Guillaume-Jugnot P; Daumas A; Magalon J; Sautereau N; Veran J; Magalon G; Sabatier F; Granel B
Curr Res Transl Med; 2016; 64(1):35-42. PubMed ID: 27140597
[TBL] [Abstract][Full Text] [Related]
15. Improving outcomes in scleroderma: recent progress of cell-based therapies.
Khanna D; Krieger N; Sullivan KM
Rheumatology (Oxford); 2023 Jun; 62(6):2060-2069. PubMed ID: 36355455
[TBL] [Abstract][Full Text] [Related]
16. [Prognosis and treatment of scleroderma].
Crickx B; Belaich S
Ann Med Interne (Paris); 1984; 135(8):624-9. PubMed ID: 6529058
[TBL] [Abstract][Full Text] [Related]
17. [Scleroderma: an update on the pathogenesis and treatment].
Garza-Rodríguez V; Villarreal-Alarcón MA; Ocampo-Candiani J
Rev Med Inst Mex Seguro Soc; 2013; 51(1):50-7. PubMed ID: 23550408
[TBL] [Abstract][Full Text] [Related]
18. [Juvenile scleroderma].
de Mâcedo PA; Shinjo SK; Goldenstein-Schainberg C
Acta Reumatol Port; 2008; 33(3):289-97. PubMed ID: 18846006
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and pathogenesis of scleroderma.
Chen K; See A; Shumack S
Australas J Dermatol; 2003 Feb; 44(1):1-7; quiz 8-9. PubMed ID: 12581091
[TBL] [Abstract][Full Text] [Related]
20. Juvenile Scleroderma-What has Changed in the Meantime?
Adrovic A; Sahin S; Barut K; Kasapcopur O
Curr Rheumatol Rev; 2018; 14(3):219-225. PubMed ID: 29692255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
